Bressi Jerome Charles

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bressi Jerome Charles's trades of Fate Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
152.55
Quantity 92,465 -39.9%
Value US$3,809,533
Transaction date
Proposed sale
Price
202.64
Quantity 26,806
Value US$1,061,791
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-13 2025-01-10
S Sale
92,465 -39.9%
152.55
US$3,809,533 		92,465 -39.9% 152.55 US$3,809,533
2025-01-10 2025-01-10
PrS Proposed sale
26,806
202.64
US$1,061,791 		26,806 202.64 US$1,061,791